Ali Kuraishy
Senior Director, Head of Clinical Business Development Illumina
Seminars
Wednesday 1st April 2026
Accelerating Precision Medicine Through Illumina’s Global Ecosystem
10:40 am
- Expand global patient access through Illumina’s commercial and regulatory expertise
- Enable custom CDx development through Illumina’s network of assay development partners
- Utilise TruSight Oncology Comprehensive to drive biomarker identification, clinical validation, and oncology patient access throughout the world
